MedElevator
Войти в исследования Atencion primaria · 2009
[Occult renal disease and drug prescription in primary care].
Аннотация на английскомСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Peña Porta José María, Blasco Oliete Meliton, de Vera Floristan Carmen Vicente
Аннотация
OBJECTIVE: To study the prevalence of chronic kidney disease (CKD) [glomerular filtration rate (GFR) <60ml/min/1.73m(2)] and occult kidney disease (OKD) (normal serum creatinine values with GFR <60) in elderly patients.
DESIGN: Retrospective, observational study.
SETTING: Four primary care centres in the province of Huesca, Spain.
PARTICIPANTS: About 4014 patients older than 65 years were randomly selected.
MAIN MEASUREMENTS: GFR was calculated for all subjects using the four-variable modified MDRD equation. We registered all drugs prescriptions to the patients during a period of twelve months focusing on the potential nephrotoxic drugs.
RESULTS: After exclusions, GFR was estimated in 3286 patients (1424 men of 75.49+/-6.6 years and 1862 women of 76.29+/-7.04 years; P=.001). The prevalence of CKD was 21.2%. A total of 10.1% of patients (12.8% of women and 6.44% of men) had OKD. We recorded the complete drug prescription in 269 patients. Mean of all different drugs that were prescribed by patient-year was 10.69+/-5.92 (men 9.55+/-5.57 and women 11.11+/-6; P=.05)]. A large number of patients were treated with potentially dangerous drugs, particularly the non-steroidal anti-inflammatory drugs with 165 cases (61.34%), and 72% were exposed to drugs that can lead to hyperkalaemia.
CONCLUSIONS: We conclude that GFR estimation by clinical laboratories in the setting of primary care can contribute to prevent the adverse effects of inappropriate drug prescriptions.
DESIGN: Retrospective, observational study.
SETTING: Four primary care centres in the province of Huesca, Spain.
PARTICIPANTS: About 4014 patients older than 65 years were randomly selected.
MAIN MEASUREMENTS: GFR was calculated for all subjects using the four-variable modified MDRD equation. We registered all drugs prescriptions to the patients during a period of twelve months focusing on the potential nephrotoxic drugs.
RESULTS: After exclusions, GFR was estimated in 3286 patients (1424 men of 75.49+/-6.6 years and 1862 women of 76.29+/-7.04 years; P=.001). The prevalence of CKD was 21.2%. A total of 10.1% of patients (12.8% of women and 6.44% of men) had OKD. We recorded the complete drug prescription in 269 patients. Mean of all different drugs that were prescribed by patient-year was 10.69+/-5.92 (men 9.55+/-5.57 and women 11.11+/-6; P=.05)]. A large number of patients were treated with potentially dangerous drugs, particularly the non-steroidal anti-inflammatory drugs with 165 cases (61.34%), and 72% were exposed to drugs that can lead to hyperkalaemia.
CONCLUSIONS: We conclude that GFR estimation by clinical laboratories in the setting of primary care can contribute to prevent the adverse effects of inappropriate drug prescriptions.